PE Tech Report


Like this article?

Sign up to our free newsletter

Pamplona acquires health information management expert Precyse

Pamplona Capital Management is to acquire Precyse, a leader in Health Information Management services, education and technology, from Altaris Capital Partners and NewSpring Capital. 

Precyse’s industry-leading expertise and technologies empower healthcare organizations to most effectively capture, organize, secure and analyze clinical data to improve financial performance and the quality of care delivered.

Precyse, founded in 1999, has enabled nearly 5,000 healthcare facilities and systems across the United States to improve efficiency and deliver tangible outcomes. The company delivers a robust combination of experienced, highly trained people; premier technology solutions; and industry-leading education, targeted at all clinical and financial aspects of Health Information Management. Collectively, this equips healthcare organisations to achieve enhanced, sustainable operational performance.

“We are delighted to be partnering with Pamplona Capital at this exciting time in Precyse’s evolution,” says Precyse CEO, Chris Powell. “Precyse has a wide range of services, education and technology solutions that enable us to help healthcare organizations thrive.  Pamplona will help us meet our growth objectives as we continue to build on our successful solutions today and expand our offerings in the future to help healthcare organizations reach new levels of operational success.”

“Precyse has established itself as a leader in Health Information Management with the ability to fully outsource HIM departments, provide services or technology on an as-needed basis, and supply education tools to help hospitals achieve better outcomes,” says Pamplona Capital partner, Dr Jeremy Gelber, who is leading the investment. “We and Precyse have a shared vision in expanding the business beyond the company’s traditional offerings into other areas that positively impact providers’ clinical and financial outcomes, both in Health Information Management and beyond.”

In addition to Precyse, Pamplona’s healthcare investment portfolio currently includes Spreemo, a company that is bringing cost transparency and quality metrics to the workers compensation specialty benefits management industry with an initial focus on radiology; Intralign, which helps hospital and surgeons achieve a rep-less, optimised surgical episode by combining assessment with clinical support and operational tools; Magnacare, a leading healthcare administrative services company focused on self-insured employers and workers comp plans in the New York and New Jersey regions; and Privia Health, a physician practice management and population health technology company.

Earlier this month, Pamplona sold the majority of its controlling stake in Alvogen, a high growth generic drugs company, to a consortium of investors.

The Precyse investment is being made from Pamplona’s fourth private equity fund, Pamplona Capital Partners IV LP, a USD 4 billion investment vehicle, raised last year.  Pamplona was advised by Deutsche Bank Securities Inc. and received legal advice from Simpson Thacher & Bartlett LLP.

Like this article? Sign up to our free newsletter